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ABSTRACT 
 
Purpose 
The aim of this article is to review the available literature on objective electromyography (EMG) 
assessment on treatment effectiveness with various occlusal splints (OS) on sleep bruxism (SB). 
 
Materials and Methods 
The dental literature was searched from 1966 - 2008 in Ovid Medline, Pre-Medline, Embase and 
all EBM Reviews: Cochrane Database of Systematic Reviews; ACP Journal Club; Database of 
Abstracts of Reviews of Effects; Cochrane Central Register of Controlled Trials, and Pre-
Medline. Studies conducted on human subjects with abstracts written in the English language 
were included. Articles not pertaining to the topic were excluded. Selected articles were graded 
according to levels of evidence based upon guidelines provided by Journal of Evidence Based 
Dental Practice (2002).  
 
Results 
The literature on electromyography assessment of treatment effectiveness with oral appliances 
worn during sleep on bruxers was scarce. Twelve articles satisfied the inclusion criteria out of 
the 104 found, and included 6 randomised controlled trials (RCTs) and 6 cohort studies. A total 
of 187 subjects were involved, predominantly female. Studies showed high methodology 
heterogeneity and splint treatment duration was generally short-term. The splint designs tested 
include maxillary stabilising splint (MSS), MSS with canine guidance or molar guidance, 
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thermoplastic vacuum formed soft splint (SS), palatal placebo ‘splint’ (PS), mandibular 
advancement splint (MAS), nociceptive trigeminal inhibitory splint (NTIS) and splint design 
according to Jeanmonod prescription (JS). 
 
Conclusion 
Large heterogeneity exists in study methodology. There is moderate evidence that MSS could 
significantly reduce SB activity in most patients in the short-term. This effect appears to be 
immediate. However when the splint was discontinued, SB immediately returned to pre-
treatment levels in most subjects. Long-term splint therapy should be investigated. There is little 
or no evidence to support the use of other splint designs over the MSS in terms of clinical 
effectiveness, comfort and lack of long term complications. Objective changes in SB activity do 
not always correlate to subjective changes in clinical signs or symptoms of SB. Increased 
bruxism is found in some patients with occlusal splint therapy. As this effect is currently 
unpredictable, patient interview as well as clinical splint monitoring should be employed by all 
treating physicians. 
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INTRODUCTION 
Sleep bruxism (SB) is defined as a stereotypical jaw movement disorder, characterised by 
grinding or clenching of teeth, occurring in a subject’s otherwise normal sleep.1 This common 
phenomenon should only be considered pathological when there are associated symptoms 
including increased occlusal wear, tooth and prosthesis damage, tooth mobility, myofascial pain 
or other temporomandibular disorders and sleep disturbance to the patient and/or their bed-
partner.2 
While the aetiology of SB is not fully understood, most believe it is multifactorial and may 
encompass central factors (e.g. sleep arousal) and psychosocial factors (e.g. stress and 
personality). Most authors today no longer subscribe to the occlusal discrepancy model of 
bruxism aetiology and occlusal therapy has not been shown to be successful for sleep bruxism.3 
The majority of recent literature suggests that SB appears to be regulated mainly by central 
factors.4 Regardless of its aetiology, SB involves increased activity of the jaw muscles during 
sleep with potential deleterious effects on the occluding apparatus whether it is the teeth and/or 
prosthesis. Therefore an aim to decrease jaw muscle activity should be one of the key factors in 
the management of SB.  
Although no treatment modality has been found to resolve SB, there are three main clinical 
management strategies: dental, pharmacological and psychobehavioural.2 Among the most 
popular management strategies used is occlusal splint therapy, which focuses primarily on dental 
occlusal protection against attrition. A recent Cochrane review conducted by Macedo and co-
workers that included 5 RCTs concluded that there is insufficient evidence that occlusal 
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appliance therapy is effective for treating sleep bruxism, but that there may be some benefit with 
regard to reducing tooth wear.5  
Most occlusal appliance studies conducted have been based primarily on clinical evaluations of 
subjective symptoms before and after appliance use without direct measurement of its effect on 
muscle activity. Symptom improvements are often difficult to quantify and their subjective 
interpretation as the only criteria for successful treatment limits the usefulness of the results. This 
is especially pertinent when the improvement of subjective symptoms is not necessarily 
correlated with a reduction in jaw muscle activity. 6  By directly measuring jaw muscle 
electromyography (EMG) during sleep, an objective level of muscle activity could be determined 
and the direct muscle effect of appliance therapy could be accurately assessed. The recently 
published Cochrane review on this topic included RCTs with and without EMG analysis.  
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AIM 
The aim of this article is to systematically review the literature on the treatment effectiveness of 
appliance therapy on SB which includes an objective EMG evaluation of masticatory muscle 
activity.  
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MATERIALS AND METHODS 
The dental literature was searched from 1966 to 6 June 2008 in Ovid Medline, Pre-Medline, 
Embase and all EBM Reviews including: all EBM Cochrane Database of Systematic Reviews, 
ACP Journal Club, Database of Abstracts of Reviews of Effects and Cochrane Central Register 
of Controlled Trials. 
The search strategy involved combining three subject headings “Sleep Bruxism”, “Occlusal 
Splints” and “Electromyography”. Additional text-word search relevant to each subject was 
employed to cover articles where a different terminology might have been used. See Table 1 for 
the Ovid Medline search strategy. 
Table 1. Search strategy for “Appliance therapy for Sleep Bruxism using Ovid Medline” 
# Search Terms Used Results 
1 exp Sleep Bruxism/   130 
2 bruxism.tw.   1026 
3 parafunction.tw.   147 
4 grinding.tw.   2420 
5 clenching.tw.   904 
6 exp Occlusal Splints/   1032 
7 splint.tw.   3993 
8 appliance.tw.   4946 
9 $guard.tw.   2971 
10 exp Electromyography/   56215 
11 nocturnal.tw.   20372 
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# Search Terms Used Results 
12 masseter.tw.   3826 
13 temporalis.tw.   1932 
14 electromyograp$.tw.   23362 
15 EMG.tw.   18296 
16 polysomnograp$.tw.   6671 
17 $PSG.tw.   1147 
18 sleep study.tw.   506 
19 1 or 2 or 3 or 4 or 5   4202 
20 6 or 7 or 8 or 9   12270 
21 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18   506 
22 19 and 20 and 21   109 
23 limit 22 to (abstracts and English language and 
humans and yr=”1966-2008”)   
98 
Definitions: “exp” = explode the broad subject term to also include all of its indented narrower 
subject terms; “tw” = text-word searching with only title and abstract information; “$” = 
unlimited truncation which retrieves all possible suffix variations of the root word indicated; 
“OR” = combine results sets into a single set inclusive of all records from the results sets 
indicated; “AND” = combine two or more results sets into a single set that contains only those 
records that the original sets had in common 
 
The same search strategy was applied for Pre-Medline, all EBM Reviews and the same subject 
headings were used for Embase. Articles without abstracts, in languages other than English and 
where the research was not conducted on human subjects were excluded. The reference list from 
each database searched was exported into a reference management system (EndNote®, version 
X1.0.1, Thomson Reuters, USA) to locate duplicate articles, which were subsequently removed. 
6 
 
Articles not pertaining to this topic were further excluded after screening by the primary author 
(BL). Articles were excluded if they included: 
• Research that did not involve sleep studies  
• Subjects who were not sleep bruxers 
• Treatment that did involve occlusal appliances 
• No EMG analysis 
• Studies with level of evidence 3 or lower.  
The reference lists of the remaining articles were searched for further studies which could be 
included in this review. However no additional suitable articles were found.  
The level of evidence for effectiveness of interventions for the included articles was graded 
according to guidelines provided by the Journal of Evidence – Based Dental Practice 2002;2:6A 
(Table 2).   
Table 2. Grading of level of evidence 
Level of 
evidence 
Clinical Studies 
1a Systematic review of RCTs 
1b RCT 
2a Systematic review of cohort studies 
2b Cohort study (retrospective) or low level RCT 
2c Outcome research 
3a Systematic review of case-control studies or 
selected reviews 
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3b Case-control studies 
4 Case series 
5 Expert opinion 
 
RESULTS 
The initial search of all four electronic databases resulted in a total of 128 articles that initially 
satisfied our criteria. The reference list from each database was exported into EndNote® (version 
X1.0.1, Thomson Reuters, USA) and after 24 duplicates were removed, a total of 104 articles 
remained for screening (Table 3).  
Table 3. Search outline from the four electronic databases 
Search outline Articles 
Ovid Medline 98 
Pre-Medline 5 
All EBM Reviews 16 
Embase 9 
Total  128 
Applicable for screening (after 
duplicates removed) 
104 
 
These articles were further assessed to satisfy our inclusion/exclusion criteria. Table 4 outlines 
the exclusion strategy applied. Case reports were excluded from the pooled data analysis but they 
are included as part of the discussion. No articles with level of evidence 3-4 were found.  
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Table 4. Exclusion criteria employed on original article group 
Exclusion criteria Articles 
Not sleep study 28 
Not sleep bruxers 27 
No occlusal splints 22 
No EMG analysis 13 
Level of evidence < 3 2 
Total articles excluded 92 
 
12 studies satisfied all criteria and were included in this literature review including 6 RCTs and 6 
cohort studies. The included studies are summaries in Table 5. 
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After pooling all 12 studies, the following outcomes were found: 
4.1 Subject Selection 
A total of 187 subjects were involved and 59% (111/187) of the subjects are female with 
a mean age of 31 years old. Bruxer inclusion criteria chosen by the studies varied and 
included one or more of the following: self and partner report, clinical signs and 
symptoms and/or baseline EMG scoring 1-4 bruxing episodes/hour. One study stated SB 
was diagnosed but the criteria used were not disclosed.18 Exclusion criteria were also 
variable and included one or more of the following: existing medical conditions (e.g. 
psychiatric, neurological and physiological), sleep disorder, medication use, addiction to 
alcohol, coffee or substance abuse, presence of dental infection, on-going physical or 
dental therapy, gross malocclusion, large number of teeth absent and current or previous 
use of removable prosthesis. Subjects with pre-treatment for SB related symptoms were 
excluded from only 2 studies.11,14 
4.2 Splint Designs 
Splint designs tested include: maxillary stabilising splint (MSS), thermoplastic vacuum 
formed soft splint (SS), palatal ‘splint’ (PS), mandibular advancement splint which 
maintained the mandible in a protruded jaw position (MAS), nociceptive trigeminal 
inhibitory splint, which covered the anterior teeth only (NTIS) and a splint design 
according to Jeanmonod, which is a flat retro-incisal anterior splint providing a posterior 
occlusal clearance of approximately 0.4mm (JS). MSS was the most common splint 
design used and accounted for nearly half (49%) of the subjects (Table 6).  
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Table 6. Pooled number of subjects with various splint designs used 
Splint Design Pooled 
Number of 
Subjects 
MSS 144 
PS 35 
JS  16 
MAS 13 
NTIS  10 
SS  10 
No appliance (control) 64 
 
 
4.3 Splint Treatment Protocol 
Duration of splint use varied in duration between 1-42 days was a mean duration of 18 
days. Most studies advocated night time use only with the exception of 2 which indicated 
full-time use.8,14 
4.4 EMG Recording Protocol 
Eight studies conducted EMG recording at the subject’s home,7-12,15,17 while the 
remaining 4 studies were conducted in a sleep laboratory.13,14,16,18  Muscle sites measured 
varied: 6 studies measured unilateral masseter muscle,7-9,11,12,15 4 studies measured 
bilateral masseters,13,14,16,17 1 study measured unilateral masseter and anterior 
temporalis10 and 1 measured bilateral masseters and anterior temporalis muscles.18 Prior 
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to splint therapy, pre-treatment baseline EMG recording varied in duration between 1-14 
days. Whenever applicable, most studies included a ‘washout’ period of no splint use to 
reduce the potential carry-over benefits from the previous splint design before the second 
splint was used, although 1 study did not.13 The total duration of EMG recorded varied in 
duration between 1-48 days with the mean duration being 25 days.  
4.5 Maxillary Stabilising Splint (MAS) 
Most studies on MSS showed a significant decrease in SB EMG during treatment 
compared to pre-treatment in most subjects,7-10,12,13, 15,16 although two studies did not 
agree.14,17 While some subjects showed no change in SB EMG during treatment,12 other 
subjects showed an increase.8,11,13-16 One study found that on a group level, MSS did not 
significantly decrease SB EMG during the 2-6 weeks follow-up. However on an 
individual level, 44% of the subjects did show a constant reduction of EMG throughout 
the 6 weeks.15 MSS generally produced immediate SB EMG reduction and this remained 
low during treatment.7 Immediately after MSS was discontinued, most subjects 
experienced a return to pre-treatment EMG levels,7-9 although their symptoms remain 
improved.8 MSS appears to be more effective in subjects with symptoms moderate rather 
than severe symptoms related to SB.8 No subjects developed TMD symptoms after 
treatment.12 
MSS with canine guidance or molar guidance did not significantly reduce SB EMG 
activity in most subjects and no significant differences were found between the two splint 
designs in terms of SB EMG, clinical signs and symptoms and pain scores.11 
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4.6 Soft Splint (SS) 
SS decreased SB EMG by more than 25% compared to pre-treatment in only 10% of 
subjects but increased EMG by more than 25% in 70% of subjects. After being treated 
with SS, 60% of subjects developed TMD symptoms.12 
4.7 Palatal ‘Splint’ (PS) 
PS significantly decreased SB EMG compared to pre-treatment in all studies,13,15 with the 
exception of one.14 One study found that on a group level, PS decreased SB EMG only in 
the first 2 nights and made no difference during the 2-6 weeks follow-up. However on an 
individual level, 38% of subjects showed a constant reduction of EMG throughout the 6 
weeks’ period.15 In a small number of subjects, the SB EMG during treatment increased 
after using PS.15 No statistical significant difference was found in SB EMG between MSS 
and PS designs on a group level.13-15 Subjects rated MSS and PS designs equally 
comfortable but 71% felt MSS offered more tooth protection. At the 1 year follow-up of 
7/9 available subjects, 4 were still using their MSS, 1 was still using a PS and 2 had 
stopped using either.13  
4.8 Mandibular Advancement Splint (MAS) 
MAS-free, MAS-min or MAS-max significantly decreased SB EMG compared to pre-
treatment in most subjects, particularly for the MAS-min and MAS-max designs. Sixty 
two percent of subjects reported moderate pain after using MAS-min and MAS-max 
designs. Fifty four percent of subjects reported moderate mouth dryness after using 
MAS-min comparing to MSS. MSS was rated most comfortable to wear followed by 
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MAS-free, MAS-min and MAS-max. Most subjects preferred to wear MSS and rated it 
more efficient when compared to MAS-free, MAS-min and MAS-max designs.16 
4.9 Nociceptive Trigeminal Inhibitory Splint (NTIS) 
NTIS significantly decreased SB EMG compared to pre-treatment in most subjects. 
However it made no significant difference to pain scores, pain characteristics, muscle 
pain sites and maximum unassisted jaw opening.17 
4.10 Jeanmonod Splint (JS) 
JS significantly decreased SB EMG compared to pre-treatment on a group level.18 
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DISCUSSION 
5.1 Study Methodology 
With subject selection in most studies, sleep bruxers were selected on the basis of self-
report and clinical signs and symptoms instead of objective EMG evaluation. According 
to Lavigne and colleagues, sleep bruxers involved in research studies should have more 
than four bruxism episodes/hour, more than 6 bursts/episode and/or more than 25 
bursts/hour,19 only one study used these criteria.16  Without these objective criteria, it is 
difficult to ascertain whether the populations studied were actually sleep bruxers. 
Most studies constructed MSS following guidelines recommended by Ramfjord and Ash. 
The appliance included a stable flat plane occlusion with posterior centric stops and 
uniform incisor and canine rise to provide freedom in lateral and protrusive movements.20  
However their construction varied in terms of coverage area (most studies had MSS that 
covered teeth and palatal tissues but a few studies had ones that only covered teeth), 
splint thickness (ranging from 1-2mm at incisor region to 4mm at incisor region; 1mm at 
1st molar region to 2.5mm at 1st molar region or 1-2mm at 2nd molar region) and material 
used (most used heat cured resin except one study which used a thermoplastic vacuum-
formed soft splint for the fitting surface with the addition of self-curing resin to achieve a 
hard occlusal surface).10 Nevertheless, most MSS demonstrated effectiveness which 
suggests that these variables are not important considerations in the design of MSS used 
for SB. 
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Compared to actual duration of splint use in clinical situations, the mean splint treatment 
duration found in this review is relatively short. The objective effects of long-term splint 
treatment are largely unknown and therefore the findings of studies with short treatment 
duration can only be confined to short-term recommendations. 
In most of the studies, subjects were instructed to wear the occlusal splints only during 
sleep. However 2 studies reported full-time use,8,14 where one reported MSS significantly 
reducing SB EMG8 while the other reported the contrary for both MSS and PS.14 Full-
time use of occlusal splints could be a potential confounding factor due to its habituation 
effect. Harada and colleagues found that wearing either MSS or PS for short durations 
significantly decreased SB EMG compared to pre-treatment. However for treatment 
provided longer than 2 weeks, neither splints produced any significant decrease in SB 
EMG. This effect was only applicable at a group level.15 
A case report by Rugh and Solberg was one of the earliest published EMG studies on SB 
treated with MSS. This was the longest study conducted where a single subject wore an 
MSS for 8 weeks, followed by EMG recording at home for 2 weeks with MSS, 1 week 
without and finally 2 weeks with MSS again. It was found that SB EMG remained low 
during MSS use (up to 10 weeks). EMG levels immediately increased to pre-treatment 
level after cessation of MSS therapy. However this level did lower to therapeutic level 
once MSS was used again.Error! Bookmark not defined. This study demonstrated the 
successful use of EMG home recording as opposed to recordings conducted in a sleep 
laboratory. Although more information could be gathered with polysomnography from a 
sleep laboratory, patients are usually less willing to participate due to disruption of 
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lifestyle. This measuring location can also be a potential confounding factor as recordings 
are made not within the subject’s natural sleeping environment. The additional advantage 
offered by portable EMG units used at home is the economic feasibility for long-term 
studies. 
Surface EMG is sometimes contested as being an accurate method for muscle activity 
investigation because the results could be influenced by neighbouring muscles and fatty 
tissues. Visser and colleagues have demonstrated in a study with masseter and temporalis 
muscles that there is no significant influence from electrode placement on the 
reproducibility of EMG recordings.21 Also the relocation of electrodes as a source of 
error seems to be less important than often estimated.22 
Although all studies included at least a unilateral masseter muscle as a site of recording, 
not all studies included the contralateral muscle or the temporalis muscle. The difficulty 
in EMG studies is to determine which muscle was to be used to best represent SB activity 
in the presence of multiple muscle activity. The advantage of using multiple muscles is 
when one electrode failed to record properly, there are others still recording and acting as 
back-up.  
Lavigne and colleagues found that the results for left and right masseter muscles were 
similar, which was not surprising as the masticatory system is a bilateral system.23 
However some studies found the contrary, where asymmetry existed in the contraction 
pattern, suggesting that parafunction may be a unilateral phenomenon and therefore 
bilateral muscles should always be recorded for proper comparison.18,24 
22 
 
5.2 Splint Designs and Outcomes 
The reduced bruxing frequency produced by MSS use can be explained in several ways, 
depending on the preferred aetiological theory. If occlusal interferences are believed to be 
precursors to bruxing, then splint therapy can be viewed as removal of interferences by 
providing an occlusally balanced acrylic surface between the teeth.Error! Bookmark not 
defined. However, Riise and Sheikholeslam reported that in subjects with TMD created 
experimentally by the insertion of a single occlusal interference (high amalgam filling), 
the EMG pattern of postural muscle did not change significantly 1 hour after the 
interference was eliminated. Therefore, the reduction of muscle activity could not be due 
to elimination or modification of the patient’s occlusal interferences. 25  Visser and 
colleagues suggested that the EMG changes observed during splint therapy could be the 
result of splint-induced sensory changes from an altered condylar position or increased 
working length of masticatory muscles. There may also be altered sensory input from 
periodontal ligament receptors, the tongue, lips and the oral mucosa.26 Some authors 
reported that increasing the occlusal vertical dimension beyond the clinical rest position 
could cause a reduction of elevator muscle EMG activity. The decrease in muscle activity 
as a result of an increase in vertical dimension suggests the presence of reciprocal 
activation of the motor neurons of the jaw depressor muscles and simultaneous inhibition 
of the elevators.27,28  
Two studies did not report a statistically significant decrease in EMG when subjects were 
treated with MSS.14,17 Possible explanations could be that one study instructed the subject 
to use their MSS on a full-time basis 14 while the other had a small sample size where a 
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post hoc calculation indicated that a sample size of 24 was needed to demonstrate a 
statistically significant difference.17 
MSS constructed with canine guidance is based on D’amico’s belief that periodontal 
feedback from canines could reduce masticatory muscular forces.29  MSS constructed 
with molar guidance is based on Lous’ use of a “pivot splint” that has contacts only in the 
second molar which relieved temporomandibular joint clicking and other symptoms.30 
The fact that patients have shown clinical improvement with well-adjusted anterior 
guidance splints has led clinicians to conclude that canine guidance is an important 
feature of splint design. However the study by Rugh et al. found that there is no 
significant difference in treatment effectiveness between MSS with canine guidance vs. 
MSS with first molar guidance.11 It is likely that something other than canine guidance is 
responsible for the positive clinical effects. The common clinical assumption that the 
therapeutic mechanism of splint therapy is via a reflexive inhibition of muscle activity 
through canine guidance is not supported by this study. These results suggest that the 
rationale and design of splints may need to be re-examined. 
Increased SB activity has been found in subjects using a SS. 12 The vertical dimension as 
well as tissue coverage for the two splint designs used (SS and MSS) were very similar 
and eliminates these as potential confounders. Even though the occlusal guidance of the 
two splint designs could not be made identical, it is unlikely that this played a major role 
in this result.  It is however possible that the acclimatised effect of using the SS appliance 
as a second appliance after the MSS appliance as well as a reduced periodontal feedback, 
resulted in the increased SB EMG.  
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A case report by Cassisi and colleagues was one of the first studies to objectively report 
treatment outcome using PS. This study used an intra-subject cross-over model over a 
period of 5 weeks and found that both PS and MSS (control) significantly reduced 
bruxing frequency compared to no-splint, and there was no significant difference in 
effectiveness between the two splint designs. However the bruxing duration and 
amplitude were not visually distinguishable.Error! Bookmark not defined. The reduced SB 
EMG produced by the PS can be viewed as a placebo effect because the appliance did not 
directly alter tooth contacts or mandibular position. The beneficial effects of the palatal 
splint have been noted by Greene and Laskin and were explained as a stomatognathic 
alteration (an indirect occlusal separation effect).31 Young has shown that placement of a 
2.5mm thick acrylic palatal appliance increased interocclusal distance (freeway space) 
even when the appliance did not cover any teeth. The author postulated that mechanical 
displacement of the tongue inferiorly by 2.5mm postured the mandible inferiorly and 
produced an interocclusal separation.32  The PS used in these studies covered the palate 
just lingual to the teeth which could encroach on the afore-mentioned lateral tongue space.
   
The proposed mechanism for NTIS is the overloading of the periodontal ligaments of the 
lower incisor teeth, thereby activating nociceptive afferent fibres, which by reflex 
pathways inhibit the jaw-closing muscles and subsequently reduce muscle tension.33 
Despite the reduction in SB EMG activity, this was not associated with short-term 
reduction in TMD signs and symptoms.17 
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Jeanmonod described a flat retro-incisal anterior splint which gives a posterior occlusal 
clearance of approximately 0.4mm. This allows freedom of movement of the mandible 
and removes any potential posterior intercuspation contacts.34 The study on JS found a 
significant decrease in bruxism activity vs. pre-treatment on a group level. The author 
postulated that the reduction is due to a reflex inhibition of jaw muscle activity as a result 
of the sensory information gathered from the periodontal ligament of anterior teeth during 
contact with the splint.18 
Subjects showing increased muscle activity during splint therapy are often reported: 
Clark et al. - 5/25 subjects,8 Rugh et al. - 4/8 subjects,11 Dube et al. - 1/9 subjects,13 van 
der Zaag et al. – 10/21 subjects,14 Harada et al. – 1/16 subjects15 and Landry et al. - 1/13 
subjects.16 Holmgren and colleagues postulated that in extremely hypertonic muscles, the 
increase in interocclusal distance can stretch the muscle spindles of the mandibular 
elevators to such an extent that the afferent feedback from these causes additional 
increase of tonic activity. Moreover, opening of the mouth beyond the clinical rest 
position can stimulate pain and other receptors in severely injured muscles, tendons 
and/or joints, which in turn can influence and even increase muscle contraction. Pressure 
from the splint to already periodontally traumatised teeth due to bruxism can also 
stimulate periodontal pain receptors, which may result in increased muscle tension.35  
However for studies using PS where there is no increase of vertical dimension or 
excessive pressure placed on teeth, there has been subjects showing increased SB 
activity.14 
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This study confirmed previous reports that subjective improvement of symptoms does not 
necessarily correlated with objective reduction of muscle activity. Some potential 
explanations include: redistribution of oral forces, reducing parafunctional activity during 
waking hours (full-time use of occlusal splints) or the placebo effect of having “specialist 
treatment”. This poor correlation decreases the validity of splint studies using only 
subjective outcome reports by patients.6 
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CONCLUSION 
For the 12 studies included in this review, there is large heterogeneity in study 
methodology on key factors including SB inclusion and exclusion criteria, muscle(s) 
measured, splint treatment protocol and EMG recording protocol.  
The MSS has been studied the most with convincing evidence that it could significantly 
reduce SB activity during its use in the short-term. Although this reduction appears to be 
immediate, it is not permanent. Once the splint was discontinued, SB activities 
immediately returned to pre-treatment levels in most subjects. Long-term splint therapy 
should therefore be investigated. 
There is some evidence that PS could achieve similar outcomes as MSS, but however this 
appliance design lacks the important component of dental occlusal protection.  
There is little evidence that partial coverage splints (NTIS and JS) could significantly 
reduce SB activity. These designs could produce irreversible complications with tooth 
intrusion or over-eruption when used on an extended basis. There is little or no evidence 
at present on repositioning (MAS) and pivot splints (MSS with molar guidance) and their 
effectiveness comparing to MSS. Therefore, these appliances must be considered 
experimental. There is contraindication for using a soft splint to manage patients with SB. 
It is unclear whether a particular occlusal pattern is necessary for the observed effects. 
However, the use of a poorly fitting or poorly adjusted splint is not recommended as it 
may cause unpredictable teeth movement or aggravate symptoms of jaw dysfunction. 
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Objective changes in SB EMG activity are not always correlated to subjective changes in 
clinical signs or symptoms of SB. These inconsistencies are commonly found in pain 
studies and point to the need for objective as well as subjective outcome measures. 
Increased bruxism is commonly found in some patients with occlusal splint therapy. As 
this effect is currently unpredictable, patient review as well as splint monitoring should 
be employed by all treating physicians. 
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